StemCell Institute — Investor Relations & Filings
StemCell Institute Inc. is a private cord blood bank established in 1999. The company specializes in the collection, processing, and long-term cryopreservation of stem cells from umbilical cord blood and umbilical cord tissue. Its services are targeted at expectant parents who wish to store these biological materials for potential future use in regenerative medicine and cell therapies for their child or family members. The company operates a state-of-the-art cell processing center and a large-scale cryopreservation facility. It is the largest private cord blood bank in its domestic market, holding over 99% market share and storing more than 80,000 units. StemCell Institute is the only private bank in its region to have released stored units for clinical applications, including treatments for conditions such as leukemia and cerebral palsy. The company is ISO 9001 certified.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 取締役及び補欠監査役の候補者選任に関するお知らせ | 2026-05-20 | Japanese | |
| ストック・オプション（新株予約権）の発行に関するお知らせ | 2026-05-20 | Japanese | |
| 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-12-01 | Japanese | |
| 確認書 | 2025-11-14 | Japanese | |
| 半期報告書－第27期(2025/04/01－2026/03/31) | 2025-11-14 | Japanese | |
| 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-11-04 | Japanese |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
2 filings
| |||||
| 46580522 | 取締役及び補欠監査役の候補者選任に関するお知らせ | 2026-05-20 | Japanese | ||
| 46580518 | ストック・オプション（新株予約権）の発行に関するお知らせ | 2026-05-20 | Japanese | ||
|
2025
13 filings
| |||||
| 8953930 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-12-01 | Japanese | ||
| 8318037 | 確認書 | 2025-11-14 | Japanese | ||
| 8318010 | 半期報告書－第27期(2025/04/01－2026/03/31) | 2025-11-14 | Japanese | ||
| 8070504 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-11-04 | Japanese | ||
| 7943254 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-10-01 | Japanese | ||
| 7856561 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-09-01 | Japanese | ||
| 7859626 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-08-01 | Japanese | ||
| 7242232 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-07-01 | Japanese | ||
| 7248677 | 臨時報告書 | 2025-06-26 | Japanese | ||
| 7253208 | 内部統制報告書－第26期(2024/04/01－2025/03/31) | 2025-06-24 | Japanese | ||
| 7253197 | 確認書 | 2025-06-24 | Japanese | ||
| 7253194 | 有価証券報告書－第26期(2024/04/01－2025/03/31) | 2025-06-24 | Japanese | ||
| 7260727 | 自己株券買付状況報告書（法２４条の６第１項に基づくもの） | 2025-06-02 | Japanese | ||
Market data
Market data not available
Price history
Peer group · Other human health activities n.e.c
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Personalis, Inc.
Offers advanced cancer genomics and data analysis for perso…
|
PSNL | US | Human health and social work ac… |
|
Pharmarise Holdings Corporation
A holding company that manages and operates a network of di…
|
2796 | JP | Human health and social work ac… |
|
POLYNOVO LIMITED
Develops synthetic dermal regeneration solutions for comple…
|
PNV | AU | Human health and social work ac… |
|
Precipio, Inc.
A cancer diagnostics company offering clinical services and…
|
PRPO | US | Human health and social work ac… |
|
PREDILIFE
Develops AI-powered solutions to assess individual risk for…
|
ALPRE | FR | Human health and social work ac… |
|
PT Diagnos Laboratorium Utama Tbk
Offers comprehensive health services through integrated cli…
|
DGNS | ID | Human health and social work ac… |
|
PT Prodia Widyahusada Tbk.
Leading provider of comprehensive clinical laboratory servi…
|
PRDA | ID | Human health and social work ac… |
|
Pure Health Holding PJSC
Largest integrated healthcare group in the Middle East, wit…
|
PUREHEALTH | AE | Human health and social work ac… |
|
Qol Holdings Co.,Ltd.
A holding company operating in the pharmacy, pharmaceutical…
|
3034 | JP | Human health and social work ac… |
|
QUEST DIAGNOSTICS INC
Provider of diagnostic information and a broad range of cli…
|
DGX | US | Human health and social work ac… |
StemCell Institute via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/14298/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=14298 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=14298 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=14298 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 14298}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for StemCell Institute (id: 14298)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.